Andrew Pilling
Overview
Explore the profile of Andrew Pilling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashok S, Pilling A, Lee-Kwen P, Guterman L, Weiner A
Case Rep Ophthalmol Med
. 2024 May;
2024:3878152.
PMID: 38765219
. We describe a patient with normal tension glaucoma (NTG) of several years whose management was complicated by the presence of a giant internal carotid-ophthalmic artery aneurysm. . A 72-year-old...
2.
Yaghini E, Tacconi E, Pilling A, Rahman P, Broughton J, Naasani I, et al.
Eur J Pharm Sci
. 2020 Nov;
157:105639.
PMID: 33188925
There is considerable interest in biomedical applications of quantum dot (QD) nanoparticles, in particular their use as imaging agents for diagnostic applications. In order to investigate the in vivo biodistribution...
3.
Korbmacher B, Atorf J, Fridrichs-Gromoll S, Hill M, Korte S, Kremers J, et al.
Primate Biol
. 2020 Feb;
4(1):93-100.
PMID: 32110696
To safeguard patients, regulatory authorities require that new drugs that are to be given by the intravitreal (IVT) route are assessed for their safety in a laboratory species using the...
4.
Yaghini E, Turner H, Pilling A, Naasani I, MacRobert A
Nanomedicine
. 2018 Jul;
14(8):2644-2655.
PMID: 30048815
Quantum dot (QD) nanoparticles are highly promising contrast agents and probes for biomedical applications owing to their excellent photophysical properties. However, toxicity concerns about commonly used cadmium-based QDs hinder their...
5.
Augier E, Dulman R, Damadzic R, Pilling A, Hamilton J, Heilig M
Neuropsychopharmacology
. 2017 Mar;
42(9):1789-1799.
PMID: 28294133
GABAergic signaling is involved in modulating the reinforcing properties of alcohol, and GABA receptors have been proposed as a potential target for clinical treatment of alcoholism. The orthosteric GABA receptor...
6.
Tanko L, Goldhahn J, Varela A, Lesage E, Smith S, Pilling A, et al.
Calcif Tissue Int
. 2016 May;
99(3):310-21.
PMID: 27167138
Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts strong promyogenic effects on skeletal muscle by blocking activin type II receptors (ActRII). We investigated whether such blockade of...
7.
Tapocik J, Barbier E, Flanigan M, Solomon M, Pincus A, Pilling A, et al.
J Neurosci
. 2014 Mar;
34(13):4581-8.
PMID: 24672003
Escalation of voluntary alcohol consumption is a hallmark of alcoholism, but its neural substrates remain unknown. In rats, escalation occurs following prolonged exposure to cycles of alcohol intoxication, and is...
8.
Madsen L, Knauf J, Gotfredsen C, Pilling A, Sjogren I, Andersen S, et al.
Endocrinology
. 2012 Jan;
153(3):1538-47.
PMID: 22234463
Liraglutide and exenatide are glucagon-like peptide receptor (GLP-1R) agonists used in the treatment of type 2 diabetes. Both molecules have been associated with the development of thyroid C-cell tumors after...
9.
OConnor R, Beden R, Pilling A, Chamberlain M
Clin Med (Lond)
. 2011 Mar;
11(1):40-3.
PMID: 21404783
This paper examines the reductions in care costs that result from inpatient multidisciplinary rehabilitation for younger people with acquired brain injury. Thirty-five consecutive patients admitted following a stroke over one...
10.
Haworth R, Oakley K, McCormack N, Pilling A
Toxicol Pathol
. 2005 May;
33(2):239-45.
PMID: 15902967
The aim of this study was to use immunohistochemistry with morphometry to investigate COX-1 and COX-2 expression in the normal rat gastrointestinal (GI) tract and examine if sites of ulceration...